Bleeding from gastric varices is relatively common and can be life threatening. The optimal treatment strategy for gastric variceal hemorrhage is controversial. Both interventional radiology and endoscopic therapies require a high level of clinical expertise. Which type of therapy is best? A recent study compared endoscopic cyanoacrylate glue injection with the insertion of a transjuglar intrahepatic portosystemic shunt.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kim, T. et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 25, 307–312 (1997).
Sarin, K. et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16, 1343–1349 (1992).
Lo, G. H., Lai, K. H., Cheng, J. S., Chen, M. H. & Chiang, H. T. A prospective randomised control trial of butyl cyanoacrylate injection verses band ligation in the management of bleeding gastric varices. Hepatology 33, 1060–1064 (2001).
Chao, Y. et al. Hepatic hemodynamics features in patients with esophageal or gastric varices. J. Hepatol. 19, 85–89 (1993).
Procaccini, N. J., Al-Osaimi, A. M., Northup, P., Argo, C. & Caldwell, S. H. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U. S. analysis. Gastrointest. Endosc. 70, 881–887 (2009).
Lo, G. H. et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic stent shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 39, 679–685 (2007).
Jalan, R., Elton, R. A., Redhead, D. N., Finlayson, N. D., & Hayes, P. C. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent shunt for variceal haemorrhage. J. Hepatol. 23, 123–128 (1995).
Nolte, W. et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic stent shunt in patients with cirrhosis; clinical, laboratory, psychometric and electoencephalopathic investigations. Hepatology 28, 1215–1225 (1998).
Rosado, B. & Kamath, P. S. Transjugular intrahepatic portosystemic stent shunts: an update. Liver Transpl. 9, 207–217 (2003).
Somberg, K. A. et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic stent shunts: incidence and risk factors. Am. J. Gastroenterol. 90, 549–555 (1995).
Mahadeva, S., Bellamy, M. C., Kessel, D., Davies, M. H. & Millson, C. E. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am. J. Gastroenterol. 98, 2688–2693 (2003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
McAvoy, N., Hayes, P. Endoscopic cyanoacrylate therapy for gastric variceal bleeding. Nat Rev Gastroenterol Hepatol 7, 190–191 (2010). https://doi.org/10.1038/nrgastro.2010.22
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2010.22
This article is cited by
-
Gastric Varices: Is There a Role for Endoscopic Cyanoacrylates, or Are We Entering the BRTO Era?
American Journal of Gastroenterology (2012)